Summit Therapeutics Inc.（SMMT）内部人交易：高管与董事近期交易
过去 18 个月，共有 5 位内部人为 Summit Therapeutics Inc.（SMMT）报告了 21 笔 Form 4 交易（最近一笔 2026-06-12）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-12 | DUGGAN ROBERT W | Co-Chief Executive Officer | 买入 | 3.8M | $50.0M |
| 2026-06-12 | Zanganeh Mahkam | Co-Chief Executive Officer | 买入 | 3.8M | $50.0M |
| 2026-06-04 | Zanganeh Mahkam | Co-Chief Executive Officer | 买入 | 100,000 | $1.5M |
| 2026-06-04 | Soni Manmeet Singh | COO and CFO | 买入 | 25,000 | $361,500 |
| 2026-06-04 | Soni Manmeet Singh | COO and CFO | 买入 | 25,000 | $360,750 |
| 2026-06-04 | DUGGAN ROBERT W | Co-Chief Executive Officer | 买入 | 100,000 | $1.5M |
| 2025-10-23 | Xia Yu | 董事 | 买入 | 533,617 | $10.0M |
| 2025-10-23 | Anand Bhaskar | Chief Accounting Officer | 买入 | 26,680 | $499,983 |
| 2025-10-23 | Soni Manmeet Singh | COO and CFO | 买入 | 53,361 | $999,985 |
| 2025-10-23 | DUGGAN ROBERT W | Co-Chief Executive Officer | 买入 | 14.0M | $262.0M |
| 2025-10-23 | DUGGAN ROBERT W | Co-Chief Executive Officer | 买入 | 266,808 | $5.0M |
| 2025-10-23 | DUGGAN ROBERT W | Co-Chief Executive Officer | 买入 | 26,680 | $499,983 |
| 2025-10-23 | Zanganeh Mahkam | Co-Chief Executive Officer | 买入 | 266,808 | $5.0M |
| 2025-10-23 | Zanganeh Mahkam | Co-Chief Executive Officer | 买入 | 26,680 | $499,983 |
| 2025-10-23 | Zanganeh Mahkam | Co-Chief Executive Officer | 买入 | 14.0M | $262.0M |
| 2025-09-11 | Zanganeh Mahkam | Co-Chief Executive Officer | 买入 | 333,394 | $5.9M |
| 2025-09-11 | Zanganeh Mahkam | Co-Chief Executive Officer | 买入 | 5,000 | $90,350 |
| 2025-09-11 | DUGGAN ROBERT W | Co-Chief Executive Officer | 买入 | 333,394 | $5.9M |
| 2025-09-11 | DUGGAN ROBERT W | Co-Chief Executive Officer | 买入 | 5,000 | $90,350 |
| 2025-06-02 | Zanganeh Mahkam | Co-Chief Executive Officer | 买入 | 74,545 | $196,799 |
| 2025-06-02 | DUGGAN ROBERT W | Co-Chief Executive Officer | 买入 | 74,545 | $196,799 |
来源：SEC Form 4 申报文件 · 截至 2026-06-12